Ferrari gears up for Watkins Glen race with seven cars

Benedetto Vigna Chief Executive Officer Ferrari N.V.
Benedetto Vigna Chief Executive Officer - Ferrari N.V.
0Comments

Seven Ferrari 296 GT3s are set to compete in the upcoming 6 Hours of Glen, which is part of both the IMSA SportsCar Championship and the IMSA Michelin Endurance Cup. Among the drivers are six Ferrari factory racers who recently participated in the 24 Hours of Le Mans: Alessandro Pier Guidi, James Calado, Antonio Fuoco, Davide Rigon, Daniel Serra, and Lilou Wadoux.

In the GTD Pro class, DragonSpeed will field the No. 81 Ferrari 296 GT3 with Albert Costa and Davide Rigon driving. Costa achieved a second-place finish earlier this season at Raceway Laguna Seca and secured class poles at Sebring International Raceway and Laguna Seca.

The GTD category will see five teams with Pro-Am lineups competing, including two entries from Triarsi Competizione. Onofrio Triarsi will team up with James Calado and Andrew Waite in one car while Sheena Monk, Stevan McAleer, and Mike Skeen drive another.

Manny Franco and Daniel Serra join Ben Tuck in the No. 34 Corsa Horizon 296 GT3. Both Serra and Tuck finished within the top-10 at Le Mans in their respective classes.

The No. 70 Inception Racing entry features Brendan Iribe, Frederik Schandorff, and Ollie Millroy as drivers. AF Corse will run another Ferrari for Lilou Wadoux, Alessandro Pier Guidi, and Simon Mann.

Cetilar Racing’s blue No. 47 Ferrari will be driven by Lorenzo Patrese, Giorgio Sernagiotto, and Antonio Fuoco.

Historically speaking, Ferrari has seen success at Six Hours of The Glen with four overall victories since its inception in 1968.

The event begins on Friday with practice sessions leading into Saturday’s qualifying rounds for both categories. The race itself starts Sunday at noon Eastern Time (ET), broadcast live on NBC Network with streaming options available through Peacock and IMSA’s YouTube channel for international audiences.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.